Macrophage Inflammatory Protein-2 in High Mobility Group Box 1 Secretion of Macrophage Cells Exposed to Lipopolysaccharide

被引:16
作者
Qin Chaochao [1 ]
Lou, Guohua [1 ]
Yang, Ying [1 ]
Liu, Yanning [1 ]
Hu, Ying [1 ]
Min, Zheng [1 ]
Chen, Ping [1 ]
He, Jiliang [2 ]
Chen, Zhi [1 ]
机构
[1] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Diag & Treatment Infect Dis, Sch Med,Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Publ Hlth, Dept Environm Med, Hangzhou, Zhejiang, Peoples R China
关键词
Macrophage inflammatory protein-2; Acute inflammation; Macrophages; HMGB1; NF-KAPPA-B; CHEMOKINE EXPRESSION; PROTECTS MICE; TNF-ALPHA; HMGB1; ACTIVATION; RELEASE; TARGET; DOWNSTREAM; INHIBITION;
D O I
10.1159/000478646
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background/Aims: Macrophage inflammatory protein-2 (MIP-2), a type of leukocyte chemokine, is primarily produced by macrophages, and levels increase significantly in early inflammation. However, the precise biological functions and mechanisms of MIP-2 in the development of inflammation remain unclear. The purposes of the present study were to investigate the role of MIP-2 in inflammation induced by lipopolysaccharide (LPS) in vitro and to determine the possibility of blocking the high mobility group box 1 (HMGB1) signalling pathway via MIP-2 inhibition. Methods: Macrophage cells (RAW264.7, U937 and THP-1 cells) were divided into control and treatments groups. Expression levels of interleukin-6 (IL-6), interleukin-1 beta (IL-1 beta), tumour necrosis factor-alpha (TNF-alpha), HMGB1, chemokine (C-C motif) ligand-2 (Ccl-2), Toll-like receptor-4 (TLR-4), inducible nitric oxide synthase (iNOS), phosphorylated MAPKs (p38, ERKs, JNKs), PI3K/Akts, JAKs/STAT3, I kappa B, and cytoplasmic and nuclear NF-kappa B p65 in RAW264.7 cells were detected by qRT-PCR, enzyme-linked immunosorbent assay (ELISA) or western blot assays. Results: mip-2 siRNA and an anti-MIP-2 antibody significantly reduced the expression levels of Ccl-2, TLR-4, iNOS, IL-6, IL-1 beta, HMGB1, and TNF-a in RAW264.7 cells exposed to LPS (P < 0.01). Additionally, mRNA expression levels of HMGB1 and TLR-4 in cells treated with LPS + mip-2 siRNA were significantly lower than those in cells treated with LPS alone (P < 0.01 or P < 0.05). The MIP-2 antibody significantly suppressed activation of p38-MAPK, p-STAT3, and p-Akts and translocation of NF-kappa B p65 from the cytoplasm to the nucleus in RAW264.7 exposed to LPS (P < 0.01 or P < 0.05). Conclusion: mip-2 siRNA and the MIP-2 antibody can reduce the inflammatory effects induced by LPS in macrophage cells. The mechanisms may occur through down-regulation of p38-MAPK, STAT3 and Akts phosphorylation and translocation of NF-kappa B p65. MIP-2 plays an important role in inflammation induced by LPS. (C) 2017 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:913 / 928
页数:16
相关论文
共 65 条
[1]   High Mobility Group Box1 (HMGB1) released from cancer cells induces the expression of pro-inflammatory cytokines in peritoneal fibroblasts [J].
Abe, Anna ;
Kuwata, Takeshi ;
Yamauchi, Chisako ;
Higuchi, Youichi ;
Ochiai, Atsushi .
PATHOLOGY INTERNATIONAL, 2014, 64 (06) :267-275
[2]   Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial [J].
Baeten, Dominique ;
Baraliakos, Xenofon ;
Braun, Juergen ;
Sieper, Joachim ;
Emery, Paul ;
van der Heijde, Desiree ;
McInnes, Iain ;
van Laar, Jacob M. ;
Landewe, Robert ;
Wordsworth, Paul ;
Wollenhaupt, Juergen ;
Kellner, Herbert ;
Paramarta, Jacqueline ;
Wei, Jiawei ;
Brachat, Arndt ;
Bek, Stephan ;
Laurent, Didier ;
Li, Yali ;
Wang, Ying A. ;
Bertolino, Arthur P. ;
Gsteiger, Sandro ;
Wright, Andrew M. ;
Hueber, Wolfgang .
LANCET, 2013, 382 (9906) :1705-1713
[3]   LPS-induced chemokine expression in both MyD88-dependent and -independent manners is regulated by Cot/Tp12-ERK axis in macrophages [J].
Bandow, Kenjiro ;
Kusuyama, Joji ;
Shamoto, Mitsuo ;
Kakimoto, Kyoko ;
Ohnishi, Tomokazu ;
Matsuguchi, Tetsuya .
FEBS LETTERS, 2012, 586 (10) :1540-1546
[4]   Blockade of CXCR2 signalling: A potential therapeutic target for preventing neutrophil-mediated inflammatory diseases [J].
Boppana, Nithin B. ;
Devarajan, Asokan ;
Gopal, Kaliappan ;
Barathan, Muttiah ;
Bakar, Sazaly A. ;
Shankar, Esaki M. ;
Ebrahim, Abdul S. ;
Farooq, Shukkur M. .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2014, 239 (05) :509-518
[5]   Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation [J].
Charo, IF ;
Ransohoff, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :610-621
[6]   Escin Increases the Survival Rate of LPS-Induced Septic Mice Through Inhibition of HMGB1 Release from Macrophages [J].
Cheng, Yajun ;
Wang, Hongrui ;
Mao, Min ;
Liang, Chao ;
Zhang, Yu ;
Yang, Deijun ;
Wei, Ziran ;
Gao, Shunxiang ;
Hu, Bo ;
Wang, Lianghua ;
Cai, Qingping .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 36 (04) :1577-1586
[7]   IFN-α-driven CCL2 production recruits inflammatory monocytes to infection site in mice [J].
Conrady, C. D. ;
Zheng, M. ;
Mandal, N. A. ;
van Rooijen, N. ;
Carr, D. J. J. .
MUCOSAL IMMUNOLOGY, 2013, 6 (01) :45-55
[8]   Delayed wound healing in CXCR2 knockout mice [J].
Devalaraja, RM ;
Nanney, LB ;
Qian, QH ;
Du, JG ;
Yu, YC ;
Devalaraja, MN ;
Richmond, A .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (02) :234-244
[9]   Human gingival fibroblasts release high-mobility group box-1 protein through active and passive pathways [J].
Feghali, K. ;
Iwasaki, K. ;
Tanaka, K. ;
Komaki, M. ;
Machigashira, M. ;
Ishikawa, I. ;
Izumi, Y. .
ORAL MICROBIOLOGY AND IMMUNOLOGY, 2009, 24 (04) :292-298
[10]   Human Monocytes Engage an Alternative Inflammasome Pathway [J].
Gaidt, Moritz M. ;
Ebert, Thomas S. ;
Chauhan, Dhruv ;
Schmidt, Tobias ;
Schmid-Burgk, Jonathan L. ;
Rapino, Francesca ;
Robertson, Avril A. B. ;
Cooper, Matthew A. ;
Graf, Thomas ;
Hornung, Veit .
IMMUNITY, 2016, 44 (04) :833-846